Tim Boreham, Stockhead's small caps correspondent joins The Australian's Wealth Editor James Kirby on this week's show. They discuss how Biotech gets hit hardest of all, one reason this sector may recover first and three ASX biotech stocks for you to consider.

Your top tax hacks for FY 2026
28:11

Why residential rental income is about to move higher (again)
22:31

Separately Managed Accounts: Advisers love them, but should you?
31:04